Tell Your Story
My New Norm
Lisa tells us about her lung cancer diagnosis and what she does to get through her days and to live life.
Gryt Health
November 4, 2022
lung cancer
Take a break and read all about it
Deskside with Dr. Dan
FDA approves pralsetinib for lung cancer with RET gene fusions
Dr. Dan, Chief Medical Officer at Gryt Health breaks down the approval of pralsetinib by the FDA for lung cancer patients with RET gene fusions.
Gryt Health
August 4, 2022
Deskside with Dr. Dan
FDA grants accelerated approval to Gavreto, the second drug for adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC)
As of December 2020, the Food and Drug Administration (FDA) has granted accelerated approval to Gavreto, the second drug for adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC). Gryt Health Chief Medical Officer, Dr. Dan breaks down the announcement.
Gryt Health
June 21, 2022
Tell Your Story
You’re Still Here!
Four years into a stage IV lung cancer diagnosis, Lisa is proving the medical professionals wrong and living a large, purposeful, grateful life despite her diagnosis.
Gryt Health
April 15, 2022
